U.S. Chamber Comments on CMS's Draft Guidance on IPAY 2028

U.S. Chamber comments on the Centers for Medicare & Medicaid Services' ("CMS's") Draft Guidance implementing Initial Price Applicability Year 2028 ("IPAY 2028") of the Medicare Drug Price Negotiation Program created by the Biden Administration under the Inflation Reduction Act ("IRA").